Solstein Capital’s CME Group CME Stock Holding History

Solstein Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-25,000	Closed	-$3K	–	38
2019 Q1	$3K	Buy	25,000 +21,100	+541%	+$3.73M	0.02%	37
2018 Q4	$2K	Hold	3,900	–	–	0.01%	32
2018 Q3	$10K	Hold	3,900	–	–	0.06%	33
2018 Q2	$28K	Hold	3,900	–	–	0.13%	35
2018 Q1	$631K	Buy	+3,900	New	+$621K	2.13%	19

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $100B AUM 47.5% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Solstein Capital's CME Position: Q2 2026 in Review

Solstein Capital sold out of CME Group (CME) in Q2 2026, closing a stake of 1,359 shares — an estimated $401K sold.

Solstein Capital first reported a position in CME in Q1 2018 and held it in 30 quarters. The position peaked at $644K in Q2 2018. 1,714 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Solstein Capital reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Solstein Capital sold 1,359 CME Group shares in Q2 2026, an estimated $401K.
Solstein Capital first reported a position in CME Group in Q1 2018 and held it in 30 quarters.
Solstein Capital's CME Group position peaked at $644K in Q2 2018.
1,714 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.